long-term Results of Pediatric Cholesteatoma Surgery using Canal-Wall-Down Approach with Primary Obliteration: 5-Year Observational Study
Aaron Trinidade, FRCS (presenter); Matthew Yung, FRCS Objectives: Present the results of a 5-year longitudinal study in a pediatric population undergoing cholesteatoma surgery using a canal wall down approach with obliteration.
Methods: Prospective longitudinal study in a district general hospital from 1999 to 2013.46 children (<16 years) with cholesteatoma were included. Outcome measurements were:
(1) residual, recurrence, and recidivist cholesteatoma rates at 5 years postsurgery; (2) postoperative hearing; (3) postoperative waterproofing of the ear; (4) number of subsequent ear surgeries required.
Results: Using Kaplan-Meier analysis, the residual cholesteatoma rate at 5-years post-surgery was 6.7% at a rate of 20.9 per 1000 years of child follow-up (95% confidence interval: 7.8-55.6), representing 4 cases of residual cholesteatoma and no recurrences. No children experienced otorrhea at 5 years and the rate of definitive waterproofing was 94.8%. There was a reoperation rate of 18.3% (n = 11) at 5 years, which included planned ossiculoplasty. Regarding hearing, of the data available (n = 17), 12 children (70.6%) preserved maintained their hearing (change between -10 to =10 dB), 1 child (5.9%) had hearing gain (>10 dB), and 3 children (17.6%) had hearing reduction at 12 months postoperation. Six out of 17 children (35.3%) had a postoperative hearing level of ≤30 dB.
Conclusions: The use of a canal wall down approach with obliteration of the mastoid cavity to surgically treat cholesteatoma is safe in pediatric populations and results in a low recurrence rate and high rate of a trouble-free ear in the long term.
long-term use of Cochlear Implants in Older Adults: Results from a large
Consecutive Case Series Janet S. Choi (presenter); Kevin J. Contrera; Joshua F. Betz, MS; Caitlin R. Blake, MSPH; John K. Niparko, MD; Frank R. Lin, MD Objectives: Investigate rates of long-term use of cochlear implants (CI) in a large, consecutive case series of older adults (≥ 60 years) and characteristics associated with continuing CI use.
Methods: From 1999-2011, 447 individuals ≥60 years received their first CI at Johns Hopkins, and we successfully contacted 397 individuals (89%) to ascertain data on the individual's daily CI use averaged over the past 4 weeks. Regular CI use was defined as ≥8 hours/d. We investigated the time from implantation to the date when an individual reported discontinuing regular CI use with Kaplan-Meier and Cox proportional hazard analyses.
Results: The overall rate of regular CI use at 13.5 years of follow-up was 82.6% (95% confidence interval: 72.5-89.3%). Individuals who received a CI at 60-74 years had significantly higher rates of regular CI use at 13.5 years of follow-up (91.1%, [95% confidence interval: 83.2-95.4%], n = 251) than individuals who received a CI at ≥75 years (55.7%, [95% confidence interval: 24.9-78.1%], n = 146). The rate of discontinuing regular CI use (<8 hours per day) increased on average by 7.8% (95% confidence interval: 3.0-12.8%) per year of age at implantation.
Conclusions: Rates of long-term CI use in older adults at >10 years of follow-up exceed 80%. The rate of discontinuing regular CI use was strongly associated with older age at implantation.
Poster Presentations

P215
These results suggest that the earlier implantation of older adults, once critically low levels of speech recognition are present, is associated with greater usage of the device. Methods: This prospective study was conducted in our tertiary referral hospital between 2010 and 2013. Nineteen Hunt syndrome and 59 Bell's palsy patients were enrolled. Mononuclear cells isolated from whole blood were incubated with VZV antigen in culture plates for 40 hours. Anti IFN-γ antibody was added and the ELISPOT system counted immunostained spots indicating VZV-specific CMI. The relationship between the spots and days from the onset of palsy were compared between Hunt syndrome and Bell's palsy patients.
Results: Immediately after the onset, the number of spots in the Hunt syndrome group was much lower than in the Bell's palsy group, indicating low VZV-specific CMI. However, it increased rapidly and showed a strong positive relationship between the number of spots and days from the onset of palsy (r = 0.64) in Hunt syndrome. Several months after the onset, the number of spots in Hunt syndrome decreased gradually. In contrast, the Bell's palsy group showed no such relationship (r = -0.22).
Conclusions: These results suggest that low CMI to VZV may play an important role in VZV reactivation in the facial nerve, thus leading to facial palsy in Hunt syndrome. VZV vaccination is considered to be a candidate to promote VZVspecific CMI for the prevention of Hunt syndrome.
loop Overlay Myringoplasty versus Medial Myringoplasty: A Comparative Study
Joginder S. Gulia, MS (presenter); Samar Pal S. Yadav, MD; Sukhdeep K. Basur, MD Objectives: One of the most important factors in the success of myringoplasty is the size of the perforation. The repair of subtotal and large central perforation is less likely to be successful compared with the repair of small perforations. Loop overlay technique of myringoplasty offers an advantage in these situations and can be a viable alternative.
Methods: A prospective controlled study from January 2010 to December 2011 of inactive (mucosal) chronic otitis media with subtotal and large central perforations. Subjects: Forty cases of either sex in the age group of 18-40 years. Pt. B.D.S Post graduate Institute Medical Sciences Rohtak, India, a tertiary care center. Patients were randomly divided into 2 groups of 20 each. Group A underwent medial myringoplasty and Group B Loop overlay myringoplasty. The graft uptake rate and the preoperative and postoperative hearing thresholds in each group were analyzed. Independent variables: Size and location of the perforation, preoperative air bone gap, technique of myringoplasty used.
Results: The overall graft take-up rate in group A was 90% and in group B it was 95%. Further, the average postoperative gain in group A was 16.25 dB as compared to 18.5 dB of group B.
Conclusions: Loop overlay myringoplasty is better than medial myringoplasty in subtotal and large central perforations.
Magnetic Resonance Imaging at 1.5 T after Pediatric Cochlear Implantation without Magnet Removal
Sachin Gupta, MD (presenter); Brandon Isaacson, MD; Peter S. Roland, MD; Joe W. Kutz, MD; Tim N. Booth, MD; Roy Jacob, MD; Michael C Morriss, MD Objectives: (1) Assess the safety of 1.5 T magnetic resonance imaging (MRI) in pediatric patients with cochlear implants (CIs) and internal magnets. (2) Assess artifacts created by CI magnets.
Methods: A retrospective chart review was performed of pediatric CI patients who underwent 1.5T MRI at a university children's hospital. Binding of the CI magnet was performed before MRI, using mold material and a compressive gauze dressing. Patients were assessed for ability to complete the MRI, imaging artifact from the CI magnet, magnet position, and CI function following MRI.
Results: Four patients (mean age 65 months; range, 19-108 months), and a total of 6 CIs (2 bilateral), underwent 1.5 T MRI scans. There were 3 brain MRI studies and 1 spine. Informed parental consent was obtained. Clinical indications included leukodystrophy (2), hypertonia (1) and dystonia (1). Devices from 2 manufacturers were scanned. A CT scan was performed before the MRI scan in three-fourths of patients to assess bone thickness adjacent to the magnet. Three patients had MRI under anesthesia. The CI produced an artifact with a mean maximal AP dimension of 10.8 mm (range 7.5-15 mm) and a transverse of 5.7 mm (range 5.5-6 mm). Greatest image distortion occurred with bilateral implants. There was no change in magnet position or CI function after the MRI in all cases.
Conclusions: Pediatric patients may safely undergo 1.5 T MRI after CI without removal of the magnet if the device is tightly bound beforehand and strict safety protocols are followed. There are limitations to brain imaging due to artifacts.
